Vivos Therapeutics Inc

NASDAQ:VVOS   3:59:53 PM EDT
0.41
-0.05 (-10.62%)
Accounting Issues/SEC Inquiries, Other Pre-Announcement

Vivos Therapeutics Provides Update On Revenue Recognition Review

Published: 11/22/2022 12:44 GMT
Vivos Therapeutics Inc (VVOS) - Vivos Therapeutics Provides Update on Revenue Recognition Review.
Vivos Therapeutics Inc - Detailed Analysis Finds Minimal Impact on Prior Financial Results; No Previously Reported Revenue to Be Lost.
Vivos Therapeutics Inc - Previously Reported Q1 2022 Revenue Expected to Increase Approximately $200,000.
Vivos Therapeutics Inc - No Need to Restate Prior Year Financial Statements.
Vivos Therapeutics Inc - Restated Q1 2022 Results to Be Filed Shortly;second and Q3 2022 Financial Results Expected by Year End.